Genetic 'off switch' linked to increased risk factors for heart disease

American Heart Association Emerging Science Series Report

2013-06-20

(Press-News.org) Risk of heart and blood vessel disease may increase when a particular gene is switched off, according to preliminary research presented at the American Heart Association's Emerging Science Series Webinar. Two known biomarkers are high blood levels of certain fats – low-density lipoproteins ("bad" cholesterol) and high triglycerides. Another recognized biomarker is a protein called adiponectin, which is made in fat tissue and helps regulate the process of turning food into energy. At low levels it is associated with increased disease risk. Researchers examined these biomarkers in relation to a particular gene, called CPT1A in 888 patients from the Genetics of Lipid-Lowering Drugs and Diet Network study. The gene makes a liver enzyme that helps break down fat in food. They also monitored a biochemical process called methylation that switches off genes. During this process carbon and hydrogen atoms combine to form a compound called a methyl group, which binds to a portion of a gene and turns off its activity. "Our results open the door to the development of new screening tools and a clearer understanding of the biological mechanisms that underlie heart disease," said Stella Aslibekyan, Ph.D., study lead author and assistant professor at the University of Alabama at Birmingham. They found that patients who had methyl groups bound to CPT1A had significantly higher triglycerides and low-density lipoprotein levels, and lower adiponectin. Heart disease is the number one killer among adults in the United States, and researchers are trying to identify individual genetic differences that might increase risk. One way to do this is by studying subtle variations in indicators of disease, or biomarkers, to identify people who are at greatest risk for developing heart disease. "This is one step on the road to personalized medicine," Aslibekyan said. "In the future, we may be able to screen for methylation of CPT1A to identify at-risk individuals." ### Co-authors are Marguerite M. Irvin, Ph.D.; Jin Sha, M.S.; Degui Zhi, Ph.D.; Krista Stanton Thibeault, M.S.; Michael Y. Tsai, M.D., Ph.D.; Paul N. Hopkins, M.D.; Ingrid B. Borecki, Ph.D.; Jose M. Ordovas, Ph.D.; Devin M. Absher, Ph.D.; and Donna K. Arnett, Ph.D. The National Institutes of Health funded the study. For the latest heart and stroke news, follow @HeartNews on Twitter. Statements and conclusions of study authors published in American Heart Association scientific journals or presented at American Heart Association conferences are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding.

ELSE PRESS RELEASES FROM THIS DATE:

Higher strength statins do not increase risk of kidney injury

2013-06-20

A higher strength of cholesterol-lowering drugs, or statins, did not increase the risk of kidney injury among heart attack survivors, according to preliminary research presented at the American Heart Association's Emerging Science Series Webinar. Statins have been shown to reduce the risk of a first or recurrent heart attack, but recent observational studies suggest that high doses may be linked to a higher incidence of kidney injury. In this study, researchers analyzed data from two large clinical trials in which survivors were randomly assigned to receive either high- ...

Looking at sachet water consumption in Ghana

2013-06-20

ACCRA, GHANA (June 19, 2013) — Many of West Africa's largest cities continue to lag in their provision of piped water to residents. Filling the service gap are plastic water sachets, which have become an important source of drinking water for the region. This industry provides many jobs and improves access to clean drinking water, yet unintended social and environmental consequences associated with the widespread use of sachet water continues to stir controversy. A new study by Justin Stoler, assistant professor of Geography and Regional Studies at the University of Miami ...

Better guidance urgently needed for 'epidemic' of sleep apnea in surgical patients

2013-06-20

Although as many as 25 percent of patients undergoing surgery suffer from sleep apnea, few hospitals have policies to help manage the risks of this condition during surgery, and there is little evidence to help guide anesthesiologists and surgeons caring for these patients. In a new editorial in the New England Journal of Medicine, Stavros Memtsoudis, M.D., Ph.D., director of Critical Care Services at Hospital for Special Surgery, New York City, calls for a new research initiative to identify the safest and most effective ways to manage patients with sleep apnea. Sleep ...

Researchers report first entanglement between light and an optical atomic coherence

2013-06-20

Using clouds of ultra-cold atoms and a pair of lasers operating at optical wavelengths, researchers have reached a quantum network milestone: entangling light with an optical atomic coherence composed of interacting atoms in two different states. The development could help pave the way for functional, multi-node quantum networks. The research, done at the Georgia Institute of Technology, used a new type of optical trap that simultaneously confined both ground-state and highly-excited (Rydberg) atoms of the element rubidium. The large size of the Rydberg atoms – which ...

British women 50 percent less likley to receive treatment for common menopausal symptoms

2013-06-20

Crawley, UK-- New data, published today in Menopause International, suggests that post-menopausal women in Britain are experiencing less sex, and less satisfying sex compared to their European and North American counterparts1, because they are considerably less likely to access appropriate treatment for a common, taboo condition called vaginal atrophy1. The first-of-its-kind study, called the CLarifying vaginal atrophy's impact On SEx and Relationships (CLOSER) study, showed that British post-menopausal women with vaginal atrophy are more likely to experience less sex1, ...

Cheap, color, holographic video

2013-06-20

CAMBRIDGE, MA -- Today in the journal Nature, researchers at MIT's Media Lab report a new approach to generating holograms that could lead to color holographic-video displays that are much cheaper to manufacture than today's experimental, monochromatic displays. The same technique could also increase the resolution of conventional 2-D displays. Using the new technique, Daniel Smalley, a graduate student in the Media Lab and first author on the new paper, is building a prototype color holographic-video display whose resolution is roughly that of a standard-definition TV ...

A shot in the arm for old antibiotics

2013-06-20

Slipping bacteria some silver could give old antibiotics new life, scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University reported June 19 in Science Translational Medicine. Treating bacteria with a silver-containing compound boosted the efficacy of a broad range of widely used antibiotics and helped them stop otherwise lethal infections in mice. It helped make an antibiotic-resistant strain of bacteria sensitive to antibiotics again. And it expanded the power of an antibiotic called vancomycin that is usually only effective in killing ...

Drug shows surprising efficacy as treatment for chronic leukemia, mantle cell lymphoma

2013-06-20

COLUMBUS, Ohio – Two clinical studies published in the New England Journal of Medicine with an accompanying editorial suggest that the novel agent ibrutinib shows real potential as a safe, effective, targeted treatment for adults with chronic lymphocytic leukemia (CLL) and for patients with mantle cell lymphoma (MCL). Both studies, co-led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) and at MD Anderson Cancer Center, were published in the Journal's June ...

World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu

2013-06-20

WASHINGTON, Wednesday June 19, 2013 - The Flemish plant scientist Marc Van Montagu (born 1933) is being awarded the "World Food Prize 2013", jointly with the American scientists Mary-Dell Chilton and Robert T. Fraley. This was announced in Washington DC on Wednesday by the US Secretary of State, John Kerry. The World Food Prize - the "Nobel Prize for food and agriculture" - gives the award annually to one or more people whose work has been of exceptional social importance for the quality, quantity or availability of food. This is the first time that a Belgian has won this ...

Hartford consensus aims to improve survival after mass shootings

2013-06-20

Philadelphia, PA (June 19, 2013) – In early April, senior leaders from medical, law enforcement, military, and fire/rescue agencies met in Hartford, Connecticut, to discuss one question: how can first responders improve survival after a mass casualty event? The preliminary results of this discussion are now available in "Improving Survival from Active Shooter Events: The Hartford Consensus," a concept paper published in the June issue of the Journal of Trauma and Acute Care Surgery, official publication of the American Association for the Surgery of Trauma. The journal ...

Wiley advances Knowitall Solutions with new trendfinder application for user-friendly chemometric analysis and additional enhancements to analytical workflows

Genetic 'off switch' linked to increased risk factors for heart disease

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: